The Maximally Tolerated Dose: The Key Context for Interpreting Subtarget Medication Dosing for Heart Failure

Affiliations

¹ Duke Clinical Research Institute, Durham, North Carolina; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina. Electronic address: stephen.greene@duke.edu.
² Duke Clinical Research Institute, Durham, North Carolina; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina.

Free article

Editorial

Stephen J Greene et al. JACC Heart Fail. 2020 Sep.

Free article

. 2020 Sep;8(9):739-741.

doi: 10.1016/j.jchf.2020.05.011. Epub 2020 Aug 12.

¹ Duke Clinical Research Institute, Durham, North Carolina; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina. Electronic address: stephen.greene@duke.edu.
² Duke Clinical Research Institute, Durham, North Carolina; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina.

No abstract available

Keywords: dosing; guidelines; heart failure; medications.

Comment on

Care Gaps in Adherence to Heart Failure Guidelines: Clinical Inertia or Physiological Limitations?
Jarjour M, Henri C, de Denus S, Fortier A, Bouabdallaoui N, Nigam A, O'Meara E, Ahnadi C, White M, Garceau P, Racine N, Parent MC, Liszkowski M, Giraldeau G, Rouleau JL, Ducharme A. Jarjour M, et al. JACC Heart Fail. 2020 Sep;8(9):725-738. doi: 10.1016/j.jchf.2020.04.019. Epub 2020 Aug 12. JACC Heart Fail. 2020. PMID: 32800509